Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Assets (2016 - 2025)

Historic Assets for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $5.7 billion.

  • Select Medical Holdings' Assets rose 282.76% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 282.76%. This contributed to the annual value of $5.6 billion for FY2024, which is 2707.13% down from last year.
  • Latest data reveals that Select Medical Holdings reported Assets of $5.7 billion as of Q3 2025, which was up 282.76% from $5.7 billion recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' Assets peaked at $8.0 billion during Q2 2021, and registered a low of $5.4 billion during Q4 2022.
  • For the 5-year period, Select Medical Holdings' Assets averaged around $6.8 billion, with its median value being $7.5 billion (2022).
  • Its Assets has fluctuated over the past 5 years, first soared by 4283.31% in 2023, then plummeted by 2862.85% in 2024.
  • Over the past 5 years, Select Medical Holdings' Assets (Quarter) stood at $7.4 billion in 2021, then fell by 26.85% to $5.4 billion in 2022, then surged by 42.83% to $7.7 billion in 2023, then decreased by 27.07% to $5.6 billion in 2024, then rose by 1.39% to $5.7 billion in 2025.
  • Its Assets was $5.7 billion in Q3 2025, compared to $5.7 billion in Q2 2025 and $5.7 billion in Q1 2025.